ArchiMed completes $1.2B acquisition of Natus Medical

ArchiMed's MED Platform II fund completed its acquisition of Natus Medical, a developer of medical devices for neurological disorders, for a total equity value of $1.2 billion. Natus shareholders received $33.50 per share.

“ArchiMed’s mix of operational, medical, scientific and financial expertise will help us continue our mission to serve our customers as we internationalize and grow our business.”massdevice.com

• 2 sources
• massdevice.comArchiMed completes $1.2B acquisition of Natus MedicalSean WhooleyJul 21, 2022
• medicaldevice-network.comArchiMed acquires neurodiagnostic devices provider Natus MedicalAninda ChakrabortyJul 22, 2022

Summarized from public sources; check the original articles before acting on it.